Agenus (AGEN) Total Non-Current Liabilities (2010 - 2026)

Agenus' (AGEN) quarterly Total Non-Current Liabilities came in at $15.8 million in Q1 2026, down 92.09% year-on-year from $199.4 million in Q1 2025, and up 2.21% quarter-over-quarter from $15.4 million in Q4 2025.

Agenus (AGEN) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Agenus' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $15.8 million for Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 92.09% year-over-year to $15.8 million in Q1 2026; TTM through Mar 2026 was $15.8 million, a 92.09% decrease from a year earlier, with the FY2025 full-year figure at $15.4 million, down 93.16% from the prior year.
  • Total Non-Current Liabilities rose to $15.8 million in Q1 2026 per AGEN's latest filing, from $15.4 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $454.4 million in Q2 2022 and bottomed at $15.0 million in Q3 2025.
  • The 5-year median for Total Non-Current Liabilities is $290.9 million (2024), against an average of $268.6 million.
  • Across the five-year window, Total Non-Current Liabilities surged 141.47% in 2022 and plunged 93.67% in 2025, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $398.9 million in 2022, then dropped by 22.66% to $308.5 million in 2023, then slipped by 26.89% to $225.5 million in 2024, then plunged by 93.16% to $15.4 million in 2025, then gained by 2.21% to $15.8 million in 2026.
  • Per Business Quant, the three latest AGEN Total Non-Current Liabilities figures stand at $15.8 million (Q1 2026), $15.4 million (Q4 2025), and $15.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 4.45 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.28 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.98 Bn
4 NuCana 279.75 Bn 279.75 Bn - 949,738.67
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 746.94 Mn
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 15.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 15.78 Mn
Dec 31, 2025 15.44 Mn
Sep 30, 2025 15.04 Mn
Jun 30, 2025 184.47 Mn
Mar 31, 2025 199.44 Mn
Dec 31, 2024 225.53 Mn
Sep 30, 2024 237.71 Mn
Jun 30, 2024 290.93 Mn
Mar 31, 2024 253.83 Mn
Dec 31, 2023 308.49 Mn
Sep 30, 2023 327.16 Mn
Jun 30, 2023 372.52 Mn
Mar 31, 2023 398.94 Mn
Dec 31, 2022 398.86 Mn
Sep 30, 2022 427.55 Mn
Jun 30, 2022 454.38 Mn
Mar 31, 2022 439.87 Mn
Dec 31, 2021 464.38 Mn
Sep 30, 2021 433.90 Mn
Jun 30, 2021 188.17 Mn